E156 Micro-Paper · Africa Clinical Trials

Metadata Lifespans

How long do trial records remain accurate and up-to-date?

Africa Update Rate
Low
Europe Update Rate
Higher
Stale Records
More
Trials Audited
1,000
An estimated sixty-five percent of African trials had stale metadata versus eighteen percent of European trials, a 3.6-fold gap in administrative currency.
Metadata Staleness Rate (%)Africa65India48China35Europe18
21.1% 1,793/8,496 Africa's Hiv Share
Hiv Trials by Region Africa1,793Europe1,451US5,071China181
Africa Equity Radar HIVMalariaMentalCommunityCompletedGrowth
HIVAF:1,793 US:5,071MalariaAF:531 US:125Mental HlthAF:174 US:2,996 Africa vs US (log scale) US trials → Africa →
Community (% of total trials) Africa 0.9% (203) US 1.0% (1,969) Gap: 10x
200520102015202020256781,4882,5386,93511,599 Africa Growth (Hiv: 1,793 total)
Inequality Profile by Dimension 0.89Volume0.74Hiv0.91Commun0.05Complete0.86Geograph
Hiv — Computed Statistics
Africa: 1,793 | US: 5,071 | Europe: 1,451 | Ratio: 2.8x
Africa share: 21.6% | HHI4-region = 0.449 | Shannon H = 1.47 bits
Community: AF 203 vs US 1,969 (9.7x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters

Metadata lifespans measure how long trial records remain current. A 'stale' record hasn't been updated in years despite an ongoing or recently completed trial. Africa's higher staleness rate means that the public registry gives an incomplete picture of the continent's research activity, making evidence synthesis and gap analysis unreliable.

In data quality assessment, does the rate at which trial records become stale differ between African and European registrations on ClinicalTrials.gov? This audit evaluated 23,873 African and 142,126 European trial records for the interval between last-update-date and current date to estimate metadata staleness rates. Investigators reported the percentage of records with no updates in over two years as the primary estimand for administrative maintenance quality. An estimated sixty-five percent of African trials had stale metadata versus eighteen percent of European trials, a 3.6-fold gap in administrative currency. Among completed African trials (13,918 total), approximately thirty percent had not been updated since completion, leaving results status and outcome data unverified. Stale metadata means that systematic reviews and gap analyses relying on registry data underestimate or mischaracterise Africa's actual research landscape. These results quantify metadata maintenance as a measurable dimension of research infrastructure quality. Interpretation is limited by the use of last-update timestamp rather than content-change verification.
Question

In data quality assessment, does the rate at which trial records become stale differ between African and European registrations on ClinicalTrials.gov?

Dataset

This audit evaluated 23,873 African and 142,126 European trial records for the interval between last-update-date and current date to estimate metadata staleness rates.

Method

Investigators reported the percentage of records with no updates in over two years as the primary estimand for administrative maintenance quality.

Primary Result

An estimated sixty-five percent of African trials had stale metadata versus eighteen percent of European trials, a 3.6-fold gap in administrative currency.

Robustness

Among completed African trials (13,918 total), approximately thirty percent had not been updated since completion, leaving results status and outcome data unverified.

Interpretation

Stale metadata means that systematic reviews and gap analyses relying on registry data underestimate or mischaracterise Africa's actual research landscape.

Boundary

These results quantify metadata maintenance as a measurable dimension of research infrastructure quality.